ApoE−/−ANRIL mice developed inflammation and atherosclerosis, providing the first in vivo evidence to strongly support that ANRIL is the atherosclerotic CAD gene at the 9p21.3 CAD locus. This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.